openPR Logo
Press release

Stem Cell Umbilical Cord Blood Market: Key Trends and Opportunities 2024

07-29-2016 02:48 PM CET | Health & Medicine

Press release from: TMR - BIO

Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.

The cord blood collected during childbirth is cryopreserved and stored. UCB stem cells are stored either at private cord banks or at public cord blood banks. This preserved blood is generally used at the time of treatment of chronic ailments or transplantation, if needed, in the later stages of life.

Get Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10547

Governments around the world have been proactively financing campaigns to spread public awareness about the potential benefits of UCB stem cells. This has been a crucial factor boosting the global stem cell umbilical cord blood market in the last few years. Furthermore, such steps taken by governments also provides economic and social benefits.

The report covers the various factors influencing the growth exhibited by the stem cell umbilical cord blood market. It features an in-depth analysis of the key market drivers, restraints, and opportunities. Other highlights of the report include a market attractiveness analysis, representation of prominent enterprises in the market in terms of key shares, competitive analysis, SWOT analysis, and Porter’s five forces analysis.

UCB stem cells have emerged as an effective treatment option for over 80 diseases including immunodeficiency disorders, cancer, and other chronic blood disorders. Many of these diseases have no cure but can be treated effectively using stem cells obtained from the umbilical cord. UCB stem cells travel to the location of the damage, identify the infected cells, and then initiate a healing process. Moreover, the risk of rejection is nonexistent, because they are obtained from the same individual.

With research being underway for developing UCB stem cells to effectively treat diseases such as Alzheimer's, diabetes, heart failure, and brain tumor, the future of the global stem cell umbilical cord blood market seems very impressive. Owing to their inherent health benefits, UCB stem cells are identified as a successful mode of treatment for various life-threatening ailments.

Government authorities are also supporting clinical trials and research into cord blood stem cells, which has been a crucial factor increasing the interest of the healthcare industry and compelling major healthcare players to invest in the commercialization of UCB stem cells therapies. For instance, Cytori Therapeutics Inc., Athersys, and California Stem Cell Inc. are engaged in developing novel stem cell therapies from UCB stem cells. This is a key factor offering impetus to the global market for stem cell umbilical cord blood.

Browse Full Research Report: http://www.transparencymarketresearch.com/stem-cell-umbilical-cord-blood-market.html

Competition prevailing in the global stem cell umbilical cord blood market is currently intense, with enterprises focusing mainly on creating brand awareness. This is compelling enterprises operating in the market to formulate innovative strategies. To study the competition prevailing in the market, the report profiles companies such as Nuo Therapeutics, Teva Pharmaceuticals, Cytori Therapeutics, and others.

These companies are studied on the basis of their financial overview, business structure, supply chain network, strategies adopted, and current development status.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stem Cell Umbilical Cord Blood Market: Key Trends and Opportunities 2024 here

News-ID: 352896 • Views:

More Releases from TMR - BIO

Global Packaging and Labeling (Healthcare) Services Market: Expanding Pharmaceutical Industry to Boost Growth, predicts TMR
Global Packaging and Labeling (Healthcare) Services Market: Expanding Pharmaceut …
The global packaging and labeling services market in the healthcare domain is characterized by the presence of prominent market participants with high levels of competition.  Transparency Market Research (TMR) recently authored a report that discusses the probable vendor landscape of the global market for packaging and labeling (healthcare) services. It mentions the prevalence of significant market players such as DuPont, WestRock Company, 3M and CCL Industries. The vendors are anticipated to contribute
Global Regenerative Medicine Market Propelled by Increasing Demand for Tissue En …
The emergence of regenerative medicines has revolutionized the medical and healthcare industry across the world. The distinctive ability of these medicines to repair, restore, and regenerate tissues and organs, damaged due to injuries, diseases, or as a result of the natural aging process has opened up a wide range of applications for them. As these medicines hold the capability to restore the functionality of tissues and organs, their application in the
Global Soft Tissue Allografts Market to be Driven by Increasing Aging Population …
The soft tissue allografts market is the largest contributor towards the overall allografts market and is expected to grow progressively over the next few years. An allograft is a graft of tissue obtained from genetically dissimilar donors of the same species. Human soft tissue and bone allografts are being increasingly employed in various orthopedic and general surgical procedures. According to the Musculoskeletal Transplant Foundation, it has been estimated that almost
Microbiology Testing Technologies Market to be Driven by Rising Incidences of In …
Microbiological tests comprise the studies of various types of microbial products such as bacteria, yeast, fungus, viruses and their effects on patient population. These products provide an array of experimental approaches (i.e. synthesis and sequencing) to either modify a biological system or mimic it. Microbiology testing technologies enables to examine presence of pathogenic micro-organisms or their metabolites by means of micro-biology techniques. Get Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11603 Microbiological testing technologies

All 4 Releases


More Releases for UCB

Anticonvulsant Market - Functional Survey 2025 | GlaxoSmithKline Inc., UCB Group
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
UCB Banking Market Will Cover $19,335.6 Mn by 2020
According to a new market report published by Persistence Market Research “Global Market Study on UCB Banking - Asia-Pacific to Witness Highest Growth by 2020” the global UCB banking market is estimated at USD 13,515.8 million in 2014 and is expected to grow at a CAGR of 6.1% from 2014 to 2020, to reach an estimated value of USD 19,335.6 million in 2020. The UCB banking market is witnessing a
Global UCB Banking Market: Industry Size, Share, Growth, Forecasts
Latest industry research report on: Global UCB Banking Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Umbilical cord blood (UCB) is collected from the umbilical cord of a newborn baby and also retrieved from the placenta after delivery. It is enriched with adult stem cells and these stem cells play a vital role in regulating all biological activities and in developing tissues in the human
UCB Banking Market Will Procure $19,335.6 million in 2020
The UCB banking market is witnessing a significant growth due to the increasing prevalence of chronic diseases coupled with regenerative medicines. In addition, initiatives by various government associations have increased the importance of UCB by rising awareness about potential applications of cord blood are also supporting in the growth of the global UCB banking market. Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/umbilical-cord-blood-banking-market.asp According to a new market report published by Persistence Market Research “Global
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021. Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing
Global Stem Cell UCB Market Research Report 2016
Global Stem Cell UCB Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020. The market intelligence publication delves into the condition of the global Stem Cell UCB market. An in-depth examination of the existing market state, past progress, and forthcoming prospects of the global Stem Cell UCB market has been presented in the research report. The research publication also reports